Biomarker measurement | Time window | AKISCr/UO stage ≥ 2a | AKISCr stage ≥ 2b | ||||
---|---|---|---|---|---|---|---|
AUC-ROC | 95 % CI | P valuec | AUC-ROC | 95 % CI | P valuec | ||
Number = 181 | |||||||
▓ Enrollment UCHI3L1 | 12-h | ▓ 0.792 | ▓ 0.726–0.849 |  | ▓ 0.877 | ▓ 0.820–0.921 |  |
24-h | ▓ 0.716 | ▓ 0.644–0.780 |  | ▓ 0.901 | ▓ 0.848–0.940 |  | |
| Comparison with | Â | Â | Â | Â | Â | |
Enrollment UCr-corrected UCHI3L1 | 12-h | 0.674 | 0.601–0.742 | 0.038 | 0.832 | 0.769–0.883 | 0.359 |
24-h | 0.587 | 0.511–0.659 | 0.005 | 0.861 | 0.802–0.908 | 0.308 | |
Enrollment SCHI3L1 | 12-h | 0.645 | 0.570–0.714 | 0.071 | 0.784 | 0.717–0.842 | 0.300 |
24-h | 0.548 | 0.472–0.622 | 0.022 | 0.830 | 0.767–0.881 | 0.324 | |
Enrollment SCr | 12-h | 0.624 | 0.549–0.695 | 0.113 | 0.732 | 0.662–0.795 | 0.363 |
24-h | 0.639 | 0.565–0.709 | 0.406 | 0.766 | 0.697–0.826 | 0.278 | |
Enrollment SCr to reference SCr ratio | 12-h | 0.690 | 0.618–0.757 | 0.274 | 0.806 | 0.741–0.861 | 0.614 |
24-h | 0.695 | 0.622–0.761 | 0.784 | 0.847 | 0.786–0.896 | 0.622 | |
▓ Enrollment UNGAL | 12-h | ▓ 0.748 | ▓ 0.678–0.810 |  | ▓ 0.865 | ▓ 0.807–0.911 |  |
24-h | ▓ 0.702 | ▓ 0.630–0.768 |  | ▓ 0.886 | ▓ 0.830–0.928 |  | |
| Comparison with | Â | Â | Â | Â | Â | |
Enrollment UCr-corrected UNGAL | 12-h | 0.622 | 0.547–0.693 | 0.007 | 0.795 | 0.729–0.851 | 0.123 |
24-h | 0.570 | 0.495–0.644 | 0.001 | 0.826 | 0.763–0.878 | 0.109 | |
Number = 180d | |||||||
▓ Enrollment UCHI3L1 | 12-h | ▓ 0.791 | ▓ 0.724–0.848 |  | ▓ 0.876 | ▓ 0.819–0.921 |  |
24-h | ▓ 0.715 | ▓ 0.643–0.779 |  | ▓ 0.901 | ▓ 0.847–0.940 |  | |
| Comparison with | Â | Â | Â | Â | Â | |
UO after enrollmente | 12-h | 0.833 | 0.771–0.885 | 0.728 | 0.759 | 0.690–0.820 | 0.034 |
24-h | 0.808 | 0.743–0.863 | 0.438 | 0.795 | 0.728–0.851 | 0.022 |